Nuclear Msx2 expression was associated with low-grade (P = 0.015), ER-positive (P = 0.038) tumours, low Ki67 expression (P = 0.005), and increased nuclear cyclin D1 expression (P = 0.037). Here, MSX2 is linked to neoplasm.